NICE Talks

In this episode we discuss our consultation on NICE's routing criteria for highly specialised technologies.

Professor Jonathan Benger, our deputy chief executive and chief medical officer, outlines the proposals.

Visit the consultation page to have your say: https://www.nice.org.uk/guidance/indevelopment/GID-PMG10008/consultation/html-content

The consultation is open from Thursday 19 December 2024 and will run until Thursday 30 January 2025.

In this episode we’re going to be learning about the updated NICE guideline on the identification and management of the menopause.

Our guests are Marie Anne Ledingham, a Consultant Clinical Adviser at NICE and an NHS obstetrician and gynecologist.

And Professor Martha Hickey, consultant in Gynaecology at the Royal Women’s Hospital, Victoria, Australia and topic advisor on the NICE guideline committee.

Learn more about the guideline here:

And the discussion aid here:

In this episode we’re going to be learning about the role of NICE's independent advisory committees. How they operate, who are the members and what flexibility they have in deciding what medicines should be made available to NHS patients in England.

Our guests are NICE's director of medicines evaluation Helen Knight and Professor Steve O'Brien, one of our independent advisory committee chairman.

In this episode, we hear from Professor Jonathan Benger, NICE's deputy chief executive and interim director of our Centre for Guidelines. He's joined by Dr Bryony Kendall who is a GP and sits on NICE committees producing guidelines on women's health.

They discuss the vital role of our independent advisory committees and how you can get involved.

Find out more about joining a NICE committee: www.nice.org.uk/get-involved/our-committees

The National Institute for Health and Care Excellence has, for the first time, published a guideline on the identification and management of adrenal insufficiency, a rare condition which occurs when the adrenal glands do not produce enough essential hormones – particularly cortisol and aldosterone.

We're joined by Dr Helen Simpson, a consultant endocrinologist at UCLH NHS Foundation Trust and Sally Tollerfield an endocrine clinical nurse specialist at Great Ormond Street Hospital, to discuss the guideline and the benefits it will provide to patients and healthcare professionals.

We're joined by Mark Chapman, director of NICE's HealthTech programme and Verena Stocker, director of Innovation, Research, Life Sciences and Strategy at NHS England to discuss the benefits and opportunities the proposed pathway will offer.

Take part in the consultation: https://www.engage.england.nhs.uk/specialised-commissioning/building-an-integrated-rules-based-medtech-pathway/

In this episode, our guests reflect on 25 years of NICE, how the organisation has developed, the impact its had and how it will change to adapt to the challenges of the next 25 years.

Guests: NICE CEO Dr Sam Roberts, Chief Medical Officer for England Professor Sir Chris Whitty, MHRA CEO Dame June Raine, Director of Value and Access at Association of British HealthTech Industries Luella Trickett, and Director of the Bennett Institute for Applied Data Science Ben Goldacre.

Read more about 25 years of helping to get the best care to people fast: https://indepth.nice.org.uk/NICE-at-25/index.html

Following the publication of our new guideline, ovarian cancer: identifying and managing familial and genetic risk, the latest episode of NICETalks focuses on genetic testing and how it can help to identify those most at risk of ovarian cancer.

We talk to Ranjit Manchanda, professor of gynaecological oncology, Queen Mary University of London and Barts Health NHS Trust, Dr Judith Hayward, GP with special interest in genetics and Joanne Stanford who joined us to share her personal experience of genetic testing.

In this month's podcast, we speak with Jeanette Kusel, director of NICE Advice and Luella Trickett, director of value and access at the Association of British HealthTech Industries. They outline the benefits and opportunities NICE Advice can provide.

Go to: https://www.nice.org.uk/about/what-we-do/life-sciences/nice-advice-service?utm_medium=podcast&utm_source=nicetalks&utm_campaign=january2024&utm_term=landingpage&utm_content=linkclick

In this episode, the directors of NICE's guidance producing centres reflect on the highlights of 2023. We hear from Mark Chapman, interim director of HealthTech; Helen Knight, director of medicines evaluation; and Professor Jonathan Benger, chief medical officer and interim director of the centre for guidelines.